Followers | 246 |
Posts | 49740 |
Boards Moderated | 69 |
Alias Born | 08/29/2007 |
Friday, January 13, 2017 8:19:26 AM
Meanwhile, sitting over investors' heads are warrants issued to Roth Capital, a firm noted for making lousy (for investors) deals to keep financially strapped biomedical companies alive. Roth was issued warrants to purchase 480,000 shares at 0.25 per share. At current pricing that's about a 45 percent discount.
Here comes the pump followed by the dump.
He looks at you like you owe him money.
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM